Moffitt logo

Clinical Trials Search

Clinical Trial 19724

Cancer Type: Malignant Hematology
Interventions:

Study Type: Treatment
Phase of Study: N/A
Investigators:

  • Frederick Locke

Call 813-745-6100
or 1-800-679-0775
Overview

Study Title

Managed Access Program (MAP) To Provide Access To CTL019, For Acute Lymphoblastic Leukemia (ALL) Or Diffuse Large B-Cell Lymphoma (DLBCL) Patients With Out Of Specification Leukapheresis Product And/Or Manufactured Tisagenlecleucel Out Of Specification For Commercial Release

Summary

Objective